Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
08 2021
Historique:
received: 21 01 2021
revised: 01 04 2021
accepted: 06 04 2021
pubmed: 24 4 2021
medline: 29 12 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

Primary pure renal neuroendocrine neoplasms (R-NENs) are a distinct and rare entity. Not much is known about the histopathology and biologic behavior of these tumors. We attempted to review the clinicopathologic aspects of these neoplasms encountered at our institution. We performed a retrospective chart review to identify primary pure (not admixed with any other tumor component) R-NENs from institutional Cancer Registry database. Pathologic review of the diagnostic archival slides was done for detailed assessment of the histologic features. R-NENs were classified according to the current WHO system for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Eight pure R-NEN cases were identified, all unifocal, and most (6/8) involved the right kidney. Three patients had poorly differentiated neuroendocrine carcinoma (NEC), and five had well-differentiated neuroendocrine tumor (NET). All tumors were located near the renal hilum, stained diffusely with synaptophysin, variably with chromogranin, and were negative for renal site-specific marker PAX8 or for markers of renal cell carcinoma. We identified two distinct patterns of growth: one of sheets with interspersed rosettes and the other of large nests with low proliferative crowded centers and peripheral cells with higher proliferation and prominent palisading. Based on Ki-67 proliferative index, the tumors were classifiable into WHO grade 1 or grade 2 (based on GEP-NEN). All three NECs characteristically showed cytologic features intermediate between classic large and small cell type. This is the first comprehensive clinicopathologic study involving the rare group of R-NEN. Classifying and grading them according to the GEP-NEN system is of prognostic significance.

Identifiants

pubmed: 33891968
pii: S0046-8177(21)00055-1
doi: 10.1016/j.humpath.2021.04.006
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Chromogranins 0
Ki-67 Antigen 0
MKI67 protein, human 0
PAX8 Transcription Factor 0
PAX8 protein, human 0
SYP protein, human 0
Synaptophysin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Manik Amin (M)

Medical Oncology, Dartmouth Hitchcock Medical Center, NH, 03766, USA. Electronic address: aminmanik16@gmail.com.

Nikolaos Trikalinos (N)

Medical Oncology, Siteman Cancer Center, Washington University St Louis, MO, 63110, USA.

Deyali Chatterjee (D)

Pathology, The University of Texas MD Anderson Cancer Center, TX, 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH